References
- Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;13:344–346.
- Targoff IN. Immune manifestation of inflammatory muscle disease. Dis Clin North Am 1994;20:857–880.
- Targoff IN. Mesurament of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J Immunol 1987;138:2874–2882.
- Targoff IN, Arnett FC, Reichlin M. Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum 1988;31:515–524.
- Targoff IN, Arnett FC. Clinical manifestation in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990;88:241–251.
- Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Chin Investig 1993;91:2556–2564.
- Targoff IN, Trieu EP, Plot PH, Miller FW. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 1992;35:821–830.
- Hirakata M, Suwa A, Kagai S, Kron MA, Trieu EP, Mimori T, et al. Anti-KS identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999;162:2315–2320.
- Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characteri-zation of the Jo-1 antibody system. Arthitis Rheum 1980;23:881–888.
- Wasicek CA, Reichlin M, Montes M, Raghu G. Polymyositis and interstitial lung disease in a patient with anti Jo-1 prototype. Am J Med 1984;76:538–544.
- Targoff IN. Autoantibodies and muscle disease. In: Wotmann RL, editor. Diseases of skeletal muscle. Philadelphia©: Lippincott Williams & Wilkins; 2000. p 267–291.
- Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: A model for autoimmunity. Nature 1983;304:177–179.
- Dang CV, La Duca FM, Bell WR. Histidyl-tRNA synthetase, the myositis Jo-1 antigen, is cytoplasmic and unassociated with the cytoskeletal framework. Exp Cell Res 1986;164:261–266.
- Raben N, Nichols RC, Dohlman J, McPhie P, Sridhar V, Hyde C, et al. A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity andcontains the major autoantigenic epitope. J Biol Chem 1994;269:24277–24283.
- Ramsden DA, Chen J, Miller FW, Misener V, Berstein RM, Siminovitch KA, et al. Epitope mapping of the cloned human autoantigen, histidyl-tRNA synthetase. Analysis of the myositis-associated anti-Jo-1 autoimmune response. J Immunol 1989;143:2267–2272.
- Brower R, Vree Egberts W, Jongen PH, Van Engelen BGM, van Venrooij W. Frequent occurence of anti-tRNAH's autoantibodies that recognize conformational epitope in sera of patients with myositis. Arthritis Rheum 1998;41:1428–1437.
- Rosa MD, Hendricck JP, Lerner MR, Steitz JA, Reichlin M. A mammalian tRNAh's-containing antigen is recognized by the polymyositis-specific antibody anti-Jo-1. Nucleic Acids Res. 1983;11: 853–870.
- Miller FW, Waite KA, Biswas T, Plotz PH. The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci USA 1990;87:9933–9937.
- Miller FW, Twitty SA, Biswas T, Plotz PH. Origin and regulation of a disease-specific autoantibody response. Anti-genic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies. J Chin Investig 1990;85: 468–475.
- Howard OMZ, Dong HF, Yang D, Raben N, Nagaraju K, Rosen A, et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 2002;196:781–791.
- Eisenberg RA, Dyer K, Craven SY, Fuller CR, Yount WJ. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm. J Clin Investig 1985;75:1270–1277.
- Pearce DC, Yount WJ, Eisenberg RA. Subclass restriction of anti-SSB-La autoantibodies. Chin Immunol Immunopathol 1986;38:111–119.
- Lieu TS, Reimer CB, Sontheimer RD. Immunoglobulin class profile and subclass profile of the Ro/SS-A autoantibody response. J Investig Dermatol 1988;90:158–164.
- Arnett FC, Hirsch TJ, Bias WB, Nishikai M, Reichlin M. The Jo-1 antibody system in myositis: Relationship to clinical features and HLA. J Rheumatol 1981;8: 925–930.
- Garlepp MJ. Genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 1996;8:514–520.
- Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Balt) 1991;70:360–374.
- Goldstein R, Duvic M, Targoff IN, Reichlin M, McMenemy AM, Reveille JD, et al. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum 1990;33:1240–1248.
- Reveille JD, Targoff IN, Mimori T, Nguyen HC, Goldstein R, Arnett FC. MHC II alleles associated with myositis. Arthritis Rheum 1992;35:584, (Abstract).
- Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibody (ANA) in a large consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001;60:1131–1136.
- van Venrooij W, Charles P, Maini RN. The consensus workshop for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Methods 1991;140:181–189.
- Tan EM, Smolen JS, McDougl JS, Butcher BT, Conn D, Dawkins R, et al. A critical evaluation of enzyme immunoassay for detection of antinuclear autoantibodies of defined specificities. I Precision, sensitivity and specificity. Arthritis Rheum 1999;42:455–464.